Jay Yu

Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors.

Leading gold producer in the premier mining jurisdiction of Timmins, Ontario.

Ibogaine is a plant derived neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated particular effectiveness in treating opioid use disorder. When applied according to a strict safety protocol, ibogaine appears to eliminate the most painful symptoms of opioid withdrawal and provides a several month window free of drug cravings. Dr Alberto Sola, co-founder of Universal Ibogaine has administered more ibogaine treatments than any other doctor in the world. Universal Ibogaine is a life sciences company, with a mission to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a Canadian Clinical Trial, and ultimately to utilize that protocol around the globe through future licensing agreements. UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Clinic that, when paired with the ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.

Abaxx Technologies is building Smarter Markets: markets empowered by better tools, better benchmarks and better technology to drive market-based solutions to the biggest challenges that we face as a society, including climate change and the energy transition. In addition to developing and deploying financial technologies that make communication, trade, and transactions easier and more secure, Abaxx is launching Abaxx Commodity Futures Exchange and Clearinghouse, regulated by the Monetary Authority of Singapore, to support trading and risk management with physically-settled benchmark futures contracts in the commodity markets at the center of the energy transition to an electrified, low-carbon emissions economy. Abaxx is a founding shareholder in Base Carbon Inc. and the creator and producer of the SmarterMarkets™ podcast. For more information please visit abaxx.tech, abaxx.exchange, basecarbon.com and smartermarkets.media.

Our Audience Cloud's open marketplace is a single point of entry for advertisers and publishers to reach, monetize, and connect their digital audiences. Our next generation cloud-based infrastructure enables efficient liquidity for the digital advertising markets and optimizes the advertising supply-chain. Giving advertisers and media partners the data-driven power to connect their audiences, increasing return on ad-spend and inventory yield. In a transparent programmatic environment with artificial intelligence powered pre-bid ad fraud prevention. Advertisers & Marketers, Reach Your Audience. On the most advanced programmatic advertising stack with unique direct media marketplace and tools to filter, identify, and connect campaigns to the right audience. Giving marketers the ability to stop buying placements and start reaching an audience of one at scale. Media & Publishers, Optimize Your Audience. We enable media partners to optimize their inventory yield to get the greatest value from their biggest asset. Their audience. Our platform + specialists optimize the supply chain and move from selling site inventory to maximizing the value of your audiences. Target Your Audience Move beyond cookies to device fingerprint targeting & tracking. Our anonymous audience data-driven approach matches the digital DNA of audiences to connect relevant audiences to campaigns. Increasing both budget and inventory yield. Ad Fraud Prevention. The industry's first AI-based fraud prevention system that monitors activity on advertising auctions at a speed of under 10 milliseconds. Faster than any traditional detection system. With pattern recognition and device scoring, that prevents even the most advanced bots from bidding on ads.

Goldfish From Pluto is a new, all-encompassing children’s brand that focuses on environmental education, anti-bullying, and healthy living through music with a target age toddler to 8.

Airbnb was born in 2007 when two hosts welcomed three guests to their San Francisco home, and has since grown to over 5 million hosts who have welcomed over 2 billion guest arrivals in almost every country across the globe. Every day, hosts offer unique stays, experiences and services that make it possible for guests to connect with communities in a more authentic way.

TapImmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company’s next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or development-stage immunotherapeutics (i.e. checkpoint inhibitors). The company’s off-the-shelf vaccines boost patients’ immune systems to comprehensively stimulate both killer T-cells and helper T-cells to destroy cancer cells, and they are designed to work with 80% of the population. TapImmune is advancing two clinical stage T-cell vaccine candidates in multiple Phase II and Phase Ib/IIa clinical trials for treating ovarian and breast cancers, including programs in ovarian cancer that will benefit from FDA Fast Track and Orphan Disease Designation. The company is working in collaboration with industry and clinical leaders including Mayo Clinic, Memorial Sloan Kettering Cancer Center, and AstraZeneca.

Urban Athletic Apparel Made with Purpose for #YourUniverse #RespectYourUniverse ryu.com

Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors.

NANO Nuclear Energy Inc. (NASDAQ: NNE) NANO Nuclear Energy Inc. (NASDAQ: NNE) is a North American advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across five business lines: (i) cutting edge portable and other microreactor technologies, (ii) nuclear fuel fabrication, (iii) nuclear fuel transportation, (iv) nuclear applications for space and (v) nuclear industry consulting services. NANO Nuclear believes it is the first portable nuclear microreactor company to be listed publicly in the U.S. Led by a world-class nuclear engineering team, NANO Nuclear’s reactor products in development include its lead project, the patented KRONOS MMR™ Energy System, a stationary high-temperature gas-cooled reactor that is in construction permit pre-application engagement with the U.S. Nuclear Regulatory Commission (NRC) in collaboration with University of Illinois Urbana-Champaign (U. of I.), ZEUS™, a solid core battery reactor, and the space focused, portable LOKI MMR™, each representing advanced developments in clean energy solutions that are modular, on-demand capable, advanced nuclear microreactors. Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, is led by former executives from the largest transportation company in the world aiming to build a North American transportation company that will provide commercial quantities of HALEU fuel to small modular reactors, microreactor companies, national laboratories, military, and DOE programs. HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focusing on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear’s own microreactors as well as the broader advanced nuclear reactor industry. NANO Nuclear Space Inc. (NNS), is exploring the potential commercial applications of NANO Nuclear’s developing micro nuclear reactor technology in space.

Flewber is an innovative technology platform redefining what it means to travel in a private aircraft. Its mission to be “Simply Private” means providing passengers with an escape from crowded airports and security lines, allowing them the opportunity to unwind and relax while enjoying all the benefits of private travel, without the high cost associated with legacy private aircraft. With no membership or subscription fees, the pricing model is straightforward and cost-effective. Flewber leverages its state-of-the-art, proprietary mobile application and social experiences to provide air taxi services with a bespoke white glove approach for one-of-a-kind experiences.

Leading gold producer in the premier mining jurisdiction of Timmins, Ontario.